HIGHLIGHTS

Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with 67Cu-SAR-bisPSMA at the highest dose level of 12GBq.­ No dose limiting toxicities (DLTs) have been reported to date. Only one participant had one adverse event of Grade 1 reduction in neutrophil count and the participant fully recovered.  The Safety Review Committee (SRC) has recommended that the trial continues with the additional 3 participants as planned in cohort 3. All 3 participants had been heavily pre-treated and failed a number of commercial and investigational therapies prior to treatment in the trial. Despite this, 2 of the 3 participants so far have shown a reduction in Prostate Specific Antigen (PSA) levels within weeks after a single cycle of 12GBq 67Cu-SAR-bisPSMA. Recruitment has opened at clinical sites in the US for the additional 3 participants in cohort 3 for a single cycle of 12GBq of 67Cu-SAR-bisPSMA.

SYDNEY, Nov. 29, 2023 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the successful completion of the first stage of cohort 3 of the Phase I/IIa theranostic trial, SECuRE, evaluating 64Cu/67Cu-SAR-bisPSMA in patients with mCRPC where 3 participants have been treated at the highest dose level of 12GBq of 67Cu-SAR-bisPSMA. No adverse events were reported in relation to 64Cu-SAR-bisPSMA. Only 1 adverse event was reported and related to the 12GBq cycle of 67Cu-SAR-bisPSMA in 1 of the 3 participants, which was a grade 1 decrease in neutrophil count, and the patient has fully recovered. No ongoing adverse events and no DLTs have been reported and the SRC has recommended the trial progresses with the 3 additional participants as planned in cohort 3.

The SECuRE trial (NCT04868604)1 is a Phase I/IIa theranostic trial for identification and treatment of Prostate-Specific Membrane Antigen (PSMA) expressing mCRPC using 64Cu/67Cu-SAR-bisPSMA. 64Cu-SAR-bisPSMA is used to visualise PSMA expressing lesions and select candidates for subsequent 67Cu-SAR-bisPSMA therapy. The trial is a multi-centre, single arm, dose escalation trial with a cohort expansion involving up to 44 patients in the US. The aim of the trial is to determine the safety and efficacy of 67Cu-SAR-bisPSMA for the treatment of prostate cancer.

Cohort 3 of the trial has a 3+3 study design with the intent to gather and analyse data from the first 3 participants before progressing with an additional 3 participants. The initial data is very encouraging with no DLTs observed at the highest dose of 67Cu-SAR-bisPSMA (12GBq) and the SRC, responsible for assessing safety of participants and overseeing the general progress of the trial, has assessed the data and recommended the trial continues.

Cohort 3 is the last to assess single doses of 67Cu-SAR-bisPSMA and will be followed by a multi-dose cohort, pending safety evaluation. The initial 3 participants in cohort 3 were heavily pre-treated prior to entering the trial, having received multiple lines of therapy including other investigational products, radioligand therapy and chemotherapy. They continue to be monitored by their physicians for safety and treatment response as per the trial protocol. All 3 participants in cohort 3 remain on the trial following their recent administration of 12GBq of 67Cu-SAR-bisPSMA, with 2 demonstrating a PSA reduction within weeks of dosing, one of which is greater than 90% reduction and the second approximately 40% reduction to date.

Clarity’s Executive Chairperson, Dr Alan Taylor, commented, "We are excited by the PSA declines seen in almost all patients to date in cohorts 2 and 3 from just a single cycle. This result is also seen in patients that have been heavily pre-treated and have failed many other therapies that are either commercial or investigational. Moreover, the safety profile is very favorable and there have been no DLTs reported to date.

"SAR-bisPSMA was designed to be a best-in-class PSMA product as, unlike all other PSMA products in the market, it has dual targeting. The product was optimised to address the challenges of low uptake and retention in lesions that the first generation of PSMA products suffer from, and in both pre-clinical and clinical development to date we have observed two to three times the uptake of SAR-bisPSMA in lesions, followed by retention in lesions out to at least 96 hours. So far, the higher uptake and retention of product, coupled with the advantageous properties of copper-67, has shown quite impressive responses measured by PSA reductions in patients from single cycles of product to date.

"A number of patients from the SECuRE trial have either received, or will soon receive, additional doses of 67Cu-SAR-bisPSMA under the US Food and Drug Administration’s (FDA) Expanded Access Program (EAP). This demonstrates the initial clinical benefit observed in such patients after the administration of a single cycle of the product during the trial.

"As we have seen PSA reductions in the majority of patients after a single cycle of 67Cu-SAR-bisPSMA across all dose levels, which is known to be an independent prognostic indicator of improved overall survival following radio-ligand therapy2,3, we hope to achieve long-term and durable responses once we progress to the multi-dose cohorts of the trial. Furthermore, with commercial quantities of the 67Cu radioisotope now being routinely produced domestically in the US, we see a clear path to commercialisation as we can resolve the supply and manufacturing issues which have plagued the commercial launch of first-generation products. We look forward to sharing more data along with any further updates from patients who may receive single or multiple cycles of 67Cu-SAR-bisPSMA in our programs and bringing this product to the greater prostate cancer patient population," said Dr Taylor.

About SAR-bisPSMA

SAR-bisPSMA derives its name from the word "bis", which reflects a novel approach of connecting two PSMA-targeting agents to Clarity’s proprietary sarcophagine (SAR) technology that securely holds copper isotopes inside a cage-like structure, called a chelator. Unlike other commercially available chelators, the SAR technology prevents copper leakage into the body. SAR-bisPSMA is a TCT that can be used with isotopes of copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy.­

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA are unregistered products. Individual results may not represent the overall safety and efficacy of the products. The data outlined in this announcement has not been assessed by health authorities such as the US Food and Drug Administration (FDA). A clinical development program is currently underway to assess the efficacy and safety of these products. There is no guarantee that these products will become commercially available.

About Prostate Cancer

Prostate cancer is the second most common cancer diagnosed in men globally and the fifth leading cause of cancer death worldwide4. The American Cancer Institute estimates in 2023 there will be 288,300 new cases of prostate cancer in the US and around 34,700 deaths from the disease5.

About Clarity Pharmaceuticals

Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceuticals, developing targeted copper theranostics based on its SAR Technology Platform for the treatment of cancer in children and adults.

www.claritypharmaceuticals.com

References

ClinicalTrials.gov Identifier: NCT04868604, https://clinicaltrials.gov/ct2/show/NCT04868604 Rahbar K et al. PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival. Eur J Nucl Med Mol Imaging, 2018. Ahmadzadehfar H et al. Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617. Eur J Nucl Med Mol Imaging, 2017. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660 American Cancer Society: Key Statistics for Prostate Cancer, https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

For more information, please contact:

Clarity Pharmaceuticals

Dr Alan Taylor

Catherine Strong

Executive Chairman

Investor/Media Relations

[email protected]

[email protected]

+61 406 759 268

This announcement has been authorised for release by the Executive Chairperson.

Source : Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

NEW YORK and SHANGHAI, Nov. 29, 2023 /PRNewswire/ — MultiMetaVerse Holdings Limited ("MMV" or the "Company"), an animation and entertainment company for young consumers in China, announced today that it has received a letter of termination with respect to MMV’s contemplated acquisition of Taomee (the "Letter of Termination"). On September 15, 2023, MMV announced that it had entered into an acquisition agreement (the "Agreement") to acquire 100% equity in Shanghai Shengran Information Technology Co., Ltd. and associated interests pertaining to all of its consolidated variable interest entities (collectively, the "Target Group," or "Taomee"). The closing of the Agreement was conditioned upon, among others, MMV’s payment of the transaction consideration in installments within a fixed period of time. MMV received the Letter of Termination from Dongzheng Ruibo (Shanghai) Investment Center (Limited Partnership) and Orient TM Ruibo Limited (each a "Seller", and collectively, the "Sellers") terminating the Agreement citing MMV’s inability to pay the consideration within the agreed timeline pursuant to the Agreement.

MMV believes that the Target Group is a valuable asset with synergy to the Company, and intends to further pursue the transaction contemplated under the Agreement. MMV continues to engage the Sellers in negotiation regarding the acquisition of Taomee and is optimistic of the possibility of resuming the transaction when MMV secures sufficient funding for closing. In furtherance of this effort, MMV is actively seeking financing opportunities with institutions and private investors. In particular, MMV has entered into a share subscription agreement with Eagle Creek LP with a total proceed of US$15,000,000. MMV’s management is committed to raising additional funds in an effort to close the transaction.

About MultiMetaVerse Holdings Limited

MultiMetaVerse Holdings Limited (NASDAQ: MMV) is an animation and entertainment company dedicated to providing a high-quality, immersive entertainment experience through original, user-generated, and professional user-generated content. MMV commenced animation production in 2015 under its signature Aotu World brand, which has attracted a broad following with its inspiring storyline and unique graphic style, particularly among younger audiences in China. By leveraging the company’s established user base, MMV has built a diverse product portfolio, including animated content, comic books, short videos, collectibles, stationery, consumer products, and mobile games across the Aotu World brand. It has also developed and augmented new brands, stories, and characters, such as Neko Album.

For more information, please visit https://www.multi-metaverse.com/.

For investor and media inquiries, please contact:

MultiMetaVerse Holdings Limited
Investor Relations
E-mail: [email protected]

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company’s future commercial operations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company’s inability to implement its business plans, identify and realize additional opportunities, or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company’s Annual Report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Source : MultiMetaVerse Announces Updates of the Taomee Acqusition and Termination of Prior Acquisition Agreement

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

PARIS, Nov. 30, 2023 /PRNewswire/ — Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3 pharmaceutical forms. Today, the company is a world leader in the manufacture of sterile unit doses, with a production capacity of 5 billion doses and a presence on four continents. This growth is also reflected in rising sales, which should reach 500 million euros by 2023.

To view the Multimedia News Release, please click:
https://www.multivu.com/players/uk/9229051-unither-pharmaceuticals-celebrates-30-years-innovation-expertise/

Unither first implemented Blow-Fill-Seal (BFS) technology in 1995, enabling them to manufacture sterile doses of saline solutions, asthma medications, and eye drops. From 1997 onwards, the company developed its international business, first by exporting its products, then by acquiring a factory in the United States in 2013. With the acquisition of Barretos in 2015, Unither gained a foothold in Brazil. Then in 2020, an acquisition in China, inNanjing, consolidated its global footprint. In 2022, Unither further expanded its activities with the acquisition of a new site specializing in ophthalmology in São Paulo. This international development is designed to support its customers’ international industrial strategies by getting closer to their target markets.

Since its inception, Unither has been at the forefront of innovation, continuously striving to improve patients’ lives. Eric Goupil, President of Unither Pharmaceuticals, reminds the group’s vision: "We want to be recognized for making healthcare solutions that improve and simplify patients’ lives accessible to as many people as possible. We imagine new ideas, and our enthusiasm and energy enable us to realize them for the benefit of our customers.".

Jean-François Hilaire, CEO of Unither Pharmaceuticals, looks to the future: "Unither’s vocation is to support our customers in their drive for innovation and in their efforts to meet the demands of their markets. With Euroject®, our recent breakthrough in merging a single-use dose with a needle to create a ready-to-use injection system, illustrates Unither’s commitment to simplifying the lives of healthcare practitioners and patients, while keeping costs under control.".

About Unither Pharmaceuticals:  www.unither-pharma.com/about/who-are-we/

Press contact:
[email protected]

Unither Pharmaceuticals celebrates 30 years of innovation and expertise

Video – https://www.youtube.com/watch?v=lNCXXx_8wTo

Source : Unither Pharmaceuticals celebrates 30 years of innovation and expertise

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

RIYADH, Saudi Arabia, Nov. 30, 2023 /PRNewswire/ — As the world eagerly anticipates the 2023 United Nations Climate Change Conference of the Parties (COP28) in Dubai from November 30 to December 12, the King Abdullah Petroleum Studies & Research Center (KAPSARC) positions itself at the forefront, ready to contribute with invaluable energy expertise and insights to help shape the global discourse on climate strategies and policies.

Enabling Pathways to a Sustainable Future: KAPSARC’s Active Role at COP28

COP28 signifies a pivotal moment in our collective journey, working to deliver solutions that reduce greenhouse gas (GHG) emissions and limit global warming to 1.5 degrees Celsius in accordance with the Paris Agreement goals. With a central focus on global stocktake, mitigation, adaptation and finance the conference aims to provide actionable energy pathways, setting the stage for a resilient and inclusive climate future.

In anticipation of this critical event, KAPSARC’s President Fahad Alajlan expresses the center’s dedication, stating, "As a UNFCCC accredited observer, KAPSARC eagerly joins this year’s COP28, hosting an official side event and additional activities, engaging in panel discussions, and pledging to contribute expertise and insights to global initiatives combating climate challenges."

KAPSARC’s engagement in COP28 spans across diverse and critical topics, reflecting the center’s commitment to science-backed and data-driven discussions. With over 20 events and contributions from more than 15 experts spanning four critical themes, KAPSARC is poised to actively participate in this important climate dialogue.

Highlighted KAPSARC events at COP28:

Connecting the Dots for the Hydrogen Economy – December 3: Shahid Hasan, Fellow- KAPSARC. Ghassan Wakim, Zero-carbon Fuels Production and Export Director, Clean Air Task Force, Rami Shabaneh, Fellow- KAPSARC.

Decarbonizing Aviation and Maritime Sectors – December 4: Andres Felipe-Guzman, Fellow- KAPSARC, Nora Nezamuddin, Fellow- KAPSARC.

Role of LPG in Enabling the Just & Inclusive Energy Transition – December 5: Fateh Belaid, Fellow- KAPSARC.

Hard-to-abate Sectors in the Energy Transition: Bridging Gaps in Implementation & Enablers – December 6: Fahad Alajlan, President – KAPSARC Fatih Yilmaz, Fellow I- KAPSARC – Mohamad Hejazi, Director Climate & Sustainability – KAPSARC.

Launch of the 2023 Circular Carbon Economy Index – December 9: Fatih Yilmaz, Fellow, KAPSARC.

Satellite Technology for Measuring & Tracking GHG Emissions – December 10: Walid Matar- KAPSARC. Anwar Gasim, KAPSARC, Abdelrahman Muhsen, KAPSARC.

For media inquiries please contact Rami Husseini, [email protected], [email protected], +966506635580

*About KAPSARC:

KAPSARC is a leading Middle East think tank dedicated to advancing knowledge on energy, environment, and regional economic issues. Accredited observer of UNFCCC, KAPSARC actively contributes to global climate action. The mission of KAPSARC is to advance Saudi Arabia’s energy sector and inform global policies through evidence-based advice and applied research. 

Source : Enabling Pathways to a Sustainable Future: KAPSARC's Active Role at COP28

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Nov. 29, 2023 /PRNewswire/ — A news report from China.org.cn on Neolithic jade dragons in northeast China :

Neolithic Jade Dragons

https://youtu.be/RnOKYZwvjqw

The Hongshan culture is the most famous Neolithic archaeological culture in northeast China, dating back around 6,500-5,000 years ago.

Many Western scholars believe China’s civilization is only about 3,000 years old instead of 5,000 years old. The discovery and establishment of the Hongshan culture pushed the history of Chinese civilization forward by more than 1,000 years.

In the late Neolithic period, a number of jade ritual vessels notable for their special purposes, such as serving as symbols of royalty and theocracy, emerged throughout the land. The Niuheliang site of the Hongshan culture is known as the "Center of Ancient Jade" with an astonishing number of jade artifacts. Inside the large-scale cairn cemetery of the site, there are a number of large tombs, each surrounded by many small tombs. Numerous exquisite jade wares are buried in the large tombs, with the upper sections serving as altars made of soil and stones. Near the cemetery, there are also goddess temples dedicated to sacrifice, which are ceremonial places with strong religious undertones and strict hierarchical privileges. The exquisite jade ritual vessels were formed during this historical period, and their owners were doubtlessly members of the nobility with high social standing. 

The Hongshan people are particularly known for its jade dragons.

There are different opinions on the origin of dragons, such as lizards and crocodiles. It is said that the dragon head origins from horse head, cow head or pig head. Jade dragons of the Hongshan Culture are ones of the earlier images of dragon having discovered in China.

The Cultural Sit-Down with Wang Xiaohui

http://cul.china.com.cn/node_1008104.htm 

Neolithic Jade Dragons

https://www.facebook.com/chinaorgcn/videos/292024267127703/ 

https://twitter.com/chinaorgcn/status/1723897605057663149 

Source : Neolithic Jade Dragons

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

The summit showcased diverse perspectives of key thought leaders, innovators, and young changemakers on AI in education

DOHA, Qatar, Nov. 30, 2023 /PRNewswire/ — The world is at a tipping point for human evolution because machines are about to profoundly change the way we live, the way we work, and even experience what it means to be human, said Nina Schick, one of the first Generative AI experts and Founder of Tamang Ventures Limited, at WISE 11, the 11th edition of Qatar Foundation’s WISE Summit, that concluded today.

Referring to the exponential rate at which the capabilities of AI systems are advancing, Shick emphasized, "In this new age of intelligence – a revolution – the default is going to be a symbiotic relationship with machine and human working together."

In the masterclass ‘Critical Thinking in the Digital Age: AI, Information Literacy, and the Battle Against Disinformation,’ Dr. Marc Owen Jones, Associate Professor, Middle Eastern Studies Department at Hamad Bin Khalifa University, delved into the challenges faced by education systems in identifying and combating misinformation and advised on ways to tackle AI-generated propaganda.

The panel ‘AI for Common Good,’ explored the collective impact of AI applications in the fields of research, education, policy, philanthropy, and media on cultivating the next generation of leaders and problem-solvers. Her Excellency Buthaina bint Ali Al Jabr Al Nuaimi, Minister of Education and Higher Education, highlighted Qatar’s ongoing efforts as well as future plans in integrating AI into its education system.

Her Excellency the Minister commented: "Qatar is one of the early adopters of a national K-12 AI curriculum. It aims at preparing students for a workforce that increasingly involves AI technologies and skills."

Co-founder and CEO of The Wolfram Group, Conrad Wolfram, delivered a keynote speech during the closing ceremony on the critical importance of computational thinking in the age of AI. He examined the interlink of the study of mathematics and computational methods to nurturing critical thinking and creativity skills, and argued for a shift toward prioritizing the utilization of computational tools in education systems to address real-world challenges.

The two-day summit gathered nearly 7000 stakeholders in education, distinguished experts in innovation and technology, as well as young trailblazers to spark conversations focused on the safe, ethical and effective adoption of AI in global education systems.

Contact: [email protected].qa 

Source : 'WE ARE NOW AT THE DAWN OF A NEW AGE FOR INTELLIGENCE,' SAYS GLOBAL AI EXPERT AT QATAR FOUNDATION'S 2023 WISE SUMMIT

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Nov. 29, 2023 /PRNewswire/ — This is a report from China.org.cn about Tesla China:

In 30 seconds, what could you do? Maybe brush your teeth? Maybe enjoy a slice of cake? But what if I tell you something amazing happens in the same amount of time?

A Tesla Model Y rolls off the assembly line approximately every 30 seconds! Let’s take a closer look.

It’s quite remarkable, isn’t it? And guess where this is unfolding? Not in California, not in Berlin, but in Shanghai, China.

Construction of the Tesla Shanghai Gigafactory began in January 2019. Today, the factory can produce 950,000 cars each year. That’s about one car approximately every 30 seconds!

So, how does the Shanghai Gigafactory achieve this? Let’s dive in and find out!

"The advanced technology of Tesla is a big part of this achievement," said Liu Dingsen, L&D Manager, Tesla (China) Learning & Development Center to China.org.cn at the China International Supply Chain Expo in Beijing on November 29. "But it wouldn’t be possible without China’s well-established supply system."

"Our Shanghai Gigafactory works with over 400 first-tier local suppliers. Through collaboration, more than 60 Chinese suppliers have entered Tesla’s global supply system. Currently, Gigafactory Shanghai has achieved a localization rate of over 95% for components, and over 99.9% employees of Tesla China are Chinese," said Liu. "We can say that Tesla electric vehicles produced in Shanghai are truly Made-in-China cars."

In October, China exported 112,000 new energy passenger vehicles. Of these, over 43,000 cars were from Tesla China, making up nearly 40% of the total.

To understand this success story, you don’t need to visit the Shanghai factory personally. As if getting access were that easy, right? A great alternative is to visit the China International Supply Chain Expo in Beijing.

We are now at the China International Supply Chain Expo in Shunyi, the world’s first of its kind.

Here, visitors can learn about the upstream, midstream and downstream sectors of the various supply chains driving these miracles.

Among the 515 exhibitors, 132 are foreign-funded enterprises and institutions from 55 countries and regions, accounting for 26%. Many are Fortune Global 500 companies. Many are Fortune Global 500 companies.

We’re currently in the Smart Vehicle section. As we know, over half of the world’s new energy vehicles on roads are in China. So, this expo also showcases cutting-edge technologies in this industry. Let’s go and see.

Visitors can discover not only well-known automakers like GEELY and ZEEKR, but also key industry players like CATL. This leading lithium-ion battery manufacturer hails from Ningde, a city in southeastern China. Although their name might not roll off the tongue, they’re pushing the electric vehicle industry to new electrifying heights.

"The booth of CATL you are seeing now is part of the ESAE, also known as the Energy Storage Advanced Exhibition," said Fang Yue, Director and Executive Vice President of Blue Strategy at the expo.

"It showcases the products and services of 24 companies in the field of energy storage systems and power batteries that are participating in the exhibition as a consortium," said Fang.

Fang said all companies in the exhibition area have direct or indirect partnerships with each other, covering the entire energy storage industrial chain and formed a complete, stable and secure energy storage ecosystem.

"For example, you are now seeing the booth of CATL’s partner, SUNNIC. Their supercharging system can be used to charge the Shenxing superfast charging battery," said Fang. "In other words, the exhibition area is not just a showcase for certain products, but also shows a supply chain, an industrial chain and a value chain. In this way, we hope to contribute to the high-quality development of the new energy industry."

"As I said, it showcases the Bosch advanced automated driving solutions in China," said Liu Xiaofei, Director of Corporate Communication of Bosch China. "It contains, the middle screen basically showcases the driving situation in an elevated road as well as the congested area in the downtown city center situation."

Liu said Bosch developed the solutions together with its Chinese partners, the so called WeRide. At the 1st CISCE, Bosch invited four of its local suppliers like WeRide, SupplyOn, Black Sesame as well as HESAI Technology, and they are all showcasing their technology and solutions here at the booth.

"Well, at Bosch we stick to our "Local for Local" strategy and we conduct over 90% of our business in China for the local market," Liu sad. "Here in China, by actively collaborating with our local partners, we can serve our customers much better so as to make our supply chain much more resilient."

I’ve never considered myself to be a particularly skilled driver. However, exploring this section has made me optimistic that future mobility will be significantly smarter. It seems that in the future, anyone could be a good driver, as long as they’re good at talking!

But now, I have some new questions. If the future of mobility is dominated by the electric vehicles, do we have sufficient electricity?

And is there an environmentally friendly way to generate it? Watch my next video, and you’ll find the answer!

Source : How a carmaker in China rolls out an EV every 30 seconds

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

NEW YORK, Nov. 29, 2023 /PRNewswire/ — Tbay, the global leading gift card trading platform, is delighted to announce that it currently serves over 600,000 active users. Behind this massive number, it lies in Tbay’s thriving transaction volume as well as the support and trust of those 600,000 users. It is a remarkable achievement of collaboration and mutual growth between the Tbay platform and its users in this digitized world. This article will focus on some success stories from Tbay customers, as well as the core advantages of the platform, to explore the uniqueness charm of this digital trading platform.

Voice of Tbay Users’ Stories

Tbay has consistently committed to providing users with a secure and efficient trading experience. Users can also gain substantial profits through transactions on the platform. We will now share the real trading stories of two active Tbay users, Richiedoe from the United States and Anifowose Saheed from Lagos, who have been using Tbay for three years. Both of them express high praise for Tbay’s product, stating that Tbay has no gift card scams and works diligently with to safeguard users’ transaction security and user rights.

One key reason they continue to use Tbay is the monthly income of approximately $3,000 they can earn through gift card transactions. While acknowledging occasional withdrawal delays, they find Tbay’s gift card vendors are all efficient and professional. They also mention regulatory measures implemented by the platform to ensure transaction security. They appreciate Tbay’s customer service for its friendly and prompt assistance when they encounter issues on the platform.

Tbay was founded with the goal of achieving mutual success with its users. Encountering such heartwarming users allows Tbay to continuously expand its business horizons on the platform, thereby improving the quality of life and creating more opportunities to drive economic development in Africa.

Unique Advantages of Tbay: Diverse Online Activities and Generous Rewards

In the past six months, Tbay has continuously collected and implemented valuable feedback from users, introducing rewarding features and online marketing campaigns, including rate-up coupons and temporary points, helping users gain higher profits in transactions. Additionally, Tbay has launched diverse online marketing campaigns such as daily check-in rewards, spin&win lucky draws, and crazy Thursdays. Each user can earn up to 5,000 Naira in cash rewards per week through these activities. These initiatives not only bring practical benefits to customers but also enhance the enjoyment of transactions. Meanwhile, Tbay has continually upgraded and perfected its core product features, creating a more convenient and diverse trading experience for users.

Internet Technology Driving the African Economy

Tbay firmly believes in the transformative power of technology. As a company dedicated to the dissemination of internet technology, Tbay consistently utilizes advanced technological means to promote digital economic development in Africa, support digital transformation, and nurture new talents, making global business exchanges simpler.

At the same time, leveraging the advantages of technology, Tbay is committed to building a trustworthy, secure, and professional global gift card trading platform. Currently, Tbay covers the whole Europe, North America, and entire Africa region, reaching over 100 countries globally, connecting buyers and sellers worldwide and providing users with a secure and convenient digital trading experience.

Furthermore, Tbay is actively assisting small and medium-sized businesses in Africa region to get involved into the digital economy, expanding its business scope, increasing market participation, and actively promoting sustainable economic growth in Africa. Through these efforts, Tbay plays a positive role in constructing a new pattern of digital economy and promoting social prosperity.

Conclusion

Since its establishment, Tbay has always prioritized integrity as the foundation of its business and safety as the cornerstone of platform development. With the slogan "You are in safe hands," Tbay has garnered the favor of numerous users. In the future, Tbay will continue to strive to provide users with a secure trading environment in the digital economy, offer higher-quality services and more convenient trading experiences, and continually fulfill corporate social responsibility at the societal level, expanding social influence together with users towards a brighter future in the digital economy.

Tbay Website: https://tbay.store/

Source : Top Africa Gift Card Trading Platform Tbay: Users' Trading Success Stories and Its Unique Features

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network